Sabuhi Gard

Life expectancy is on the rise. Is that something that can be invested in – and if so, how?

‘We are all going to live longer, so why not invest in it?’­ seems to be the premise of Jim Mellon and Al Chalabi’s new book, Juvenescence – Investing in the Age of Longevity. Mellon and Chalabi forecast that within the next 20 years, the average life expectancy in the developed world will rise to between 110 and 120.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.

Or

Unlock more articles

REGISTER

Comments

Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in